PDB21 HEALTH CARE RESOURCE UTILIZATION AND COST IN TYPE-2 DIABETES PATIENTS RECEIVING COMBINATION SULFONYLUREA (SU) AND ROSIGLITAZONE (RSG)- THE RESULT TRIAL
May 1, 2005, 00:00
10.1016/S1098-3015(10)62954-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)62954-3/fulltext
Title :
PDB21 HEALTH CARE RESOURCE UTILIZATION AND COST IN TYPE-2 DIABETES PATIENTS RECEIVING COMBINATION SULFONYLUREA (SU) AND ROSIGLITAZONE (RSG)- THE RESULT TRIAL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)62954-3&doi=10.1016/S1098-3015(10)62954-3
First page :
Section Title :
Open access? :
No
Section Order :
391